BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31530093)

  • 1. Hepatitis C Virus Infection in the Dallas County Jail: Implications for Screening, Prevention, and Linkage to Care.
    Abe CM; Aguwa M; Zhao M; Sullivan J; Porsa E; Nijhawan AE
    Public Health Rep; 2019; 134(6):626-633. PubMed ID: 31530093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opt-out HIV and Hepatitis C Testing at the Dallas County Jail: Uptake, Prevalence, and Demographic Characteristics of Testers.
    de la Flor C; Porsa E; Nijhawan AE
    Public Health Rep; 2017; 132(6):617-621. PubMed ID: 29045799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic.
    Hoff E; Warden A; Taylor R; Nijhawan AE
    Public Health Rep; 2023; 138(2):248-258. PubMed ID: 35238249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
    Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
    Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.
    Hennessey KA; Kim AA; Griffin V; Collins NT; Weinbaum CM; Sabin K
    J Urban Health; 2009 Jan; 86(1):93-105. PubMed ID: 18622707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of hepatitis C virus infection among incarcerated persons: Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program in prisons.
    Irvin R; Landry G; Jones MR; James A; Schexnayder J; Rodriguez S; Wendell D; Barthe K; Britton E; LeSar K; Manogue S; Sugarman OK; Brown C; Burgess S; Mehta SH; Thomas DL; Robinson W;
    J Viral Hepat; 2024 Jul; 31(7):432-435. PubMed ID: 38758571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing an Epidemiologic Profile of Hepatitis C Virus Infection at the Los Angeles County Jail.
    Qureshi N; Tadesse M; Tran N; Henderson S
    Public Health Rep; 2021; 136(6):726-735. PubMed ID: 33602004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users.
    Kim AY; Nagami EH; Birch CE; Bowen MJ; Lauer GM; McGovern BH
    Hepatology; 2013 Mar; 57(3):944-52. PubMed ID: 23111904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
    Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
    Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
    Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
    Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-Based Hepatitis C Screening of Baby Boomers in a Majority Hispanic South Texas Cohort: Successes and Barriers to Implementation.
    Taylor BS; Hanson JT; Veerapaneni P; Villarreal R; Fiebelkorn K; Turner BJ
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):74-83. PubMed ID: 27168665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health Level.
    Seña AC; Willis SJ; Hilton A; Anderson A; Wohl DA; Hurt CB; Muir AJ
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):57-64. PubMed ID: 27168663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus Testing and Linkage to Care in North Carolina and South Carolina Jails, 2012-2014.
    Schoenbachler BT; Smith BD; Seña AC; Hilton A; Bachman S; Lunda M; Spaulding AC
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):98-104. PubMed ID: 27168668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
    Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
    J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program.
    Schechter-Perkins EM; Miller NS; Hall J; Hartman JJ; Dorfman DH; Andry C; Linas BP
    Acad Emerg Med; 2018 Nov; 25(11):1216-1226. PubMed ID: 29851238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of racial and ethnic disparities in hepatitis C antibody prevalence in United States correctional populations.
    Larney S; Zaller ND; Dumont DM; Willcock A; Degenhardt L
    Ann Epidemiol; 2016 Aug; 26(8):570-578.e2. PubMed ID: 27480479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Screening of the "Birth Cohort" (Born 1945-1965) and Younger Inmates of New York City Jails.
    Akiyama MJ; Kaba F; Rosner Z; Alper H; Holzman RS; MacDonald R
    Am J Public Health; 2016 Jul; 106(7):1276-7. PubMed ID: 27196656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental health, chronic and infectious conditions among pregnant persons in US state prisons and local jails 2016-2017.
    Hendricks CA; Rajagopal KM; Sufrin CB; Kramer C; Jiménez MC
    Womens Health (Lond); 2024; 20():17455057241228748. PubMed ID: 38468474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
    PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 May; 62(18):357-61. PubMed ID: 23657111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.